Skip to main content

Table 3 Ratio of Point Estimates and 90% CIs for AUC0-7 days for Prolastin-C versus Prolastin

From: Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study

 

Geometric least squares mean ratio: Prolastin-C versus Prolastin

 

Potency assay

Content assay

 

Point estimate

90% CI

Point estimate

90% CI

AUC 0-7 days , mg*h/mL

1.03

0.97-1.09

0.98

0.95-1.02